Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults
Jacob Lalezari(Quest Clinical Research (United States)), Stephen C. Piscitelli(Roivant Sciences (United States)), James F. Demarest(Triangle), Anne Shachoy‐Clark(Research Triangle Park Foundation), Kimberly K. Adkison(Research Triangle Park Foundation), Yu Lou(Zhejiang Chinese Medical University), Peter J. Piliero(Amsterdam UMC Location University of Amsterdam), Richard T. Davey(National Institutes of Health), Melanie Thompson(AIDS Research Consortium of Atlanta), Priny Kumar(Georgetown University), M. Michelle Berrey, Kristine B. Patterson(University of North Carolina at Chapel Hill)
Cited by 111
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k
Antiretroviral Therapy for HIV Infection in 1998
|JAMA|1998|1k